Recognising the growing threat of antibiotic resistance and superbugs, Ochsner Medical Center Jefferson Highway recently deployed a fleet of Xenex LightStrikeGerm-Zapping Robots.
Data analysis of the first 90 days of the program demonstrated that the hospital experienced a 49% reduction in Clostridium difficile (C.diff) and 49% reduction in overall infection rates after adding LightStrike pulsed xenon ultraviolet light room disinfection to its cleaning protocol.
LightStrike Robots quickly destroy microscopic pathogens and multi-drug resistant organisms and are used in addition to the routine cleaning procedures that currently take place as an extra level of protection against infection.
In August 2017, Ochsner deployed 10 LightStrike Robots at its Jefferson Highway campus to enhance the room disinfection process in the hospital.
The LightStrike Robots were provided under Xenex's No Risk Infection Rate Reduction Program. Ochsner evaluated the success of its LightStrike program based upon specific reductions in C.diff, methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci infection rates.
From the launch of the program and throughout its duration, the hospital's Environmental Services team was able to achieve 95% utilisation of the robots on room discharges and transfers.
As a result of the successful implementation and infection rate reductions, the hospital is expanding its program with 10 additional robots.
Xenex's germ-fighting robots use pulsed xenon, an environmentally-friendly noble gas, to create intense, Full Spectrum UV light that destroys infectious germs in less than five minutes.
Hospitals using Xenex devices have published clinical outcome studies in peer-reviewed journals showing 50-100 % decreases in C.diff, MRSA and Surgical Site Infection rates when those hospitals used the Xenex Robots to disinfect rooms.
Ochsner Health System is Louisiana's largest non-profit, academic, healthcare system. Patient care is provided across the region by Ochsner's 30 owned, managed and affiliated hospitals and more than 80 health centres and urgent care centres.
Xenex's patented Full Spectrum pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities.
Quanterix partners with leading health networks for Alzheimer's diagnosis advancements
Precision BioSciences reports FDA pre-IND feedback for PBGENE-HBV
VBI to sell manufacturing capabilities and enter new license agreement with Brii Biosciences
Ondine Biomedical's Steriwave shows promise in nasal pathogen reduction
BioSenic expands patent coverage for ATO therapeutic platform
PacBio unveils Nanobind PanDNA kit for enhanced DNA extraction solutions
Sequentify receives funding from Israel Innovation Authority
INOVIO plans BLA submission for INO-3107 as RRP treatment
ImmunityBio secures USD320m investment from Oberland Capital
Poolbeg Pharma prioritises promising RSV drug candidates identified through AI-led analysis
GHIT fund invests JPY500m in antimalarial drug clinical trial
AstraZeneca agrees acquisition of Icosavax
Versameb names new chairman of the board
Kling Bio appoints Dr Stefano Gullà as chief scientific officer